192 related articles for article (PubMed ID: 36916064)
1. The use of Nicotinamide and Nicotinamide riboside as an adjunct therapy in the treatment of glaucoma.
Goulart Nacácio E Silva S; Occhiutto ML; Costa VP
Eur J Ophthalmol; 2023 Sep; 33(5):1801-1815. PubMed ID: 36916064
[TBL] [Abstract][Full Text] [Related]
2. Glaucoma as a Metabolic Optic Neuropathy: Making the Case for Nicotinamide Treatment in Glaucoma.
Williams PA; Harder JM; John SWM
J Glaucoma; 2017 Dec; 26(12):1161-1168. PubMed ID: 28858158
[TBL] [Abstract][Full Text] [Related]
3. Nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol for a randomized, double-blind, placebo-control trial.
Leung CKS; Ren ST; Chan PPM; Wan KHN; Kam AKW; Lai GWK; Chiu VSM; Ko MWL; Yiu CKF; Yu MCY
Trials; 2022 Jan; 23(1):45. PubMed ID: 35039056
[TBL] [Abstract][Full Text] [Related]
4. The Role of NAD
Pietris J
J Nutr Sci Vitaminol (Tokyo); 2022; 68(3):151-154. PubMed ID: 35768245
[TBL] [Abstract][Full Text] [Related]
5. A Narrative Review of Nicotinamide Adenine Dinucleotide (NAD)+ Intermediates Nicotinamide Riboside and Nicotinamide Mononucleotide for Keratinocyte Carcinoma Risk Reduction.
Kahn B; Borrelli M; Libby T
J Drugs Dermatol; 2022 Oct; 21(10):1129-1132. PubMed ID: 36219044
[TBL] [Abstract][Full Text] [Related]
6. Balancing NAD
Cercillieux A; Ciarlo E; Canto C
Cell Mol Life Sci; 2022 Aug; 79(8):463. PubMed ID: 35918544
[TBL] [Abstract][Full Text] [Related]
7. Elevation of NAD
Metcalfe M; David BT; Langley BC; Hill CE
Exp Neurol; 2023 Oct; 368():114479. PubMed ID: 37454712
[TBL] [Abstract][Full Text] [Related]
8. Equilibrative Nucleoside Transporters Mediate the Import of Nicotinamide Riboside and Nicotinic Acid Riboside into Human Cells.
Kropotov A; Kulikova V; Nerinovski K; Yakimov A; Svetlova M; Solovjeva L; Sudnitsyna J; Migaud ME; Khodorkovskiy M; Ziegler M; Nikiforov A
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573263
[TBL] [Abstract][Full Text] [Related]
9. Systemic Treatment with Nicotinamide Riboside Is Protective in Two Mouse Models of Retinal Ganglion Cell Damage.
Zhang X; Zhang N; Chrenek MA; Girardot PE; Wang J; Sellers JT; Geisert EE; Brenner C; Nickerson JM; Boatright JH; Li Y
Pharmaceutics; 2021 Jun; 13(6):. PubMed ID: 34208613
[TBL] [Abstract][Full Text] [Related]
10. Purine nucleoside phosphorylase controls nicotinamide riboside metabolism in mammalian cells.
Kropotov A; Kulikova V; Solovjeva L; Yakimov A; Nerinovski K; Svetlova M; Sudnitsyna J; Plusnina A; Antipova M; Khodorkovskiy M; Migaud ME; Gambaryan S; Ziegler M; Nikiforov A
J Biol Chem; 2022 Dec; 298(12):102615. PubMed ID: 36265580
[TBL] [Abstract][Full Text] [Related]
11. Nicotinamide, Nicotinamide Riboside and Nicotinic Acid-Emerging Roles in Replicative and Chronological Aging in Yeast.
Orlandi I; Alberghina L; Vai M
Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32326437
[TBL] [Abstract][Full Text] [Related]
12. Nicotinamide riboside and caffeine partially restore diminished NAD availability but not altered energy metabolism in Alzheimer's disease.
Ryu WI; Shen M; Lee Y; Healy RA; Bormann MK; Cohen BM; Sonntag KC
Aging Cell; 2022 Jul; 21(7):e13658. PubMed ID: 35730144
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotection in Glaucoma: NAD
Petriti B; Williams PA; Lascaratos G; Chau KY; Garway-Heath DF
Cells; 2021 Jun; 10(6):. PubMed ID: 34198948
[TBL] [Abstract][Full Text] [Related]
14. Axonal Protection by Nicotinamide Riboside via SIRT1-Autophagy Pathway in TNF-Induced Optic Nerve Degeneration.
Kitaoka Y; Sase K; Tsukahara C; Fujita N; Arizono I; Takagi H
Mol Neurobiol; 2020 Dec; 57(12):4952-4960. PubMed ID: 32820458
[TBL] [Abstract][Full Text] [Related]
15. Emerging Role of Nicotinamide Riboside in Health and Diseases.
Sharma C; Donu D; Cen Y
Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235542
[TBL] [Abstract][Full Text] [Related]
16. Nicotinamide treatment robustly protects from inherited mouse glaucoma.
Williams PA; Harder JM; Cardozo BH; Foxworth NE; John SWM
Commun Integr Biol; 2018; 11(1):e1356956. PubMed ID: 29497468
[TBL] [Abstract][Full Text] [Related]
17. Extracellular vesicle encapsulated nicotinamide delivered via a trans-scleral route provides retinal ganglion cell neuroprotection.
Kim M; Kim JY; Rhim WK; Cimaglia G; Want A; Morgan JE; Williams PA; Park CG; Han DK; Rho S
Acta Neuropathol Commun; 2024 Apr; 12(1):65. PubMed ID: 38649962
[TBL] [Abstract][Full Text] [Related]
18. Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells.
Fletcher RS; Ratajczak J; Doig CL; Oakey LA; Callingham R; Da Silva Xavier G; Garten A; Elhassan YS; Redpath P; Migaud ME; Philp A; Brenner C; Canto C; Lavery GG
Mol Metab; 2017 Aug; 6(8):819-832. PubMed ID: 28752046
[TBL] [Abstract][Full Text] [Related]
19. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD
Martens CR; Denman BA; Mazzo MR; Armstrong ML; Reisdorph N; McQueen MB; Chonchol M; Seals DR
Nat Commun; 2018 Mar; 9(1):1286. PubMed ID: 29599478
[TBL] [Abstract][Full Text] [Related]
20. Nicotinamide Riboside and Dihydronicotinic Acid Riboside Synergistically Increase Intracellular NAD
Ciarlo E; Joffraud M; Hayat F; Giner MP; Giroud-Gerbetant J; Sanchez-Garcia JL; Rumpler M; Moco S; Migaud ME; Cantó C
Nutrients; 2022 Jul; 14(13):. PubMed ID: 35807932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]